Background: Ovarian tumor is a common type of gynecological neoplasm and accounts for 15-25% of all gynecological malignancies. It is associated with high mortality and an accurate histological diagnosis is essential for management of patient.
Introduction:
Ovarian tumor is a common type of gynecological neoplasm in female. A wide variety of tumor arises in ovary from its different cell lineages and fall into benign, borderline or malignant categories. 1 Ovarian cancer accounts for 15-25% of all gynecological malignancies, but is associated with the highest mortality rate (50%) in this group. The poor survival is due to the fact that they do not clinically manifest early and approximately 60-70% of the neoplasm present as either stage III or stage IV. 2, 3 As there are no screening tests or tumor markers and low cytological accuracy in predominantly cystic neoplasm, histopathology plays a key role in detection of type and nature of ovarian tumour. 4 An accurate histological diagnosis is also crucial for management of patient. Benign serous tumour was the most common type of benign tumor and seen in 60 (37.98%) cases, followed by mature cystic teratoma (table III) .
Serous cystadenocarcinoma was the most common type of malignant tumour (36.0%) followed by endometrioid carcinoma. All malignant cases, that occurred below 20 years of age were germ cell in origin (table IV) .
Both benign and malignant ovarian tumours were found in all age groups. Median ages for benign, borderline and malignant tumour were 44years, 20.5years and 47.5 years respectively. Overall, ovarian tumour was most prevalent in 20-50 years age group (table II) . Incidence of malignant ovarian tumour increased with age and was most frequent in >50 years age group (table  III) . However, in all age groups benign tumours were more frequent than malignant neoplasm. Only three cases of borderline tumour were found. Two cases occurred in 20-50 years of age and one case occurred in 0-20 years of age.
Consistency of tumours was cystic in 145 cases (77.96%), solid in 18 cases (9.68%) and solid and cystic in 23 cases (12.36%). Consistency of benign tumours was commonly cystic whereas malignant tumours were commonly solid and cystic (table V) .
Among 186 cases, information regarding laterality of tumours was found in 89 cases. Of these 10 (11.23%) cases were bilateral, 42 (47.19%) cases involved the right side and 37(41.57%) cases involved the left side of ovary. 
Discussion:
Ovarian tumour arises from different cell lineage. 1 In Pakistan, a study conducted by Ahmed et al. 5 found surface epithelial tumour were most common type of ovarian tumour (63.50%), followed by germ cell tumours (27.13%) and sex cord-stromal tumours(5.84%). In India, a study conducted by Sharma et al. 6 found surface epithelial tumours comprised 60.78%, germ cell tumours 30.39% and sex cordstromal tumours 5.88% of ovarian tumour. In Saudi Arabia, Abdullah 7 found 61.0% of ovarian tumours were surface epithelial in origin, 28.0% were germ cell in origin, 7.6% were sex cord stromal tumour and 3.4% were metastatic. Whereas in Nepal, Vaidya 8 found germ cell tumours were most common (51.52%), followed by surface epithelial tumour (43.53%) and sex cordstromal tumour(3.30%). In Nigeria and Africa, germ cell tumours were the commonest ovarian neoplasm followed by surface epithelial tumours. 9 In the western countries and in Japan, surface epithelial tumors were the most common tumour and account for 50 to 55% and 46 to 52% of ovarian tumour respectively. 8 In present study, we found surface epithelial tumours were commonest tumour according to histogenesis (60.75%) followed by germ cell tumour (31.72%) and sex -cord stromal tumour (6.54%). Our findings were quite similar with the studies conducted in India, Pakistan and Saudi Arabia but differ from the studies conducted in Nepal and Africa, where germ cell tumours were most common.
The ovarian tumour is diagnosed as benign, borderline or malignant depending on the presence of predominant cell type, pattern of growth, amount of fibrous stroma and cellular atypia with invasiveness. 1 In India, in a study it was found that 78.4% of ovarian tumours were benign, 20.6% were malignant and 0.98 % cases were borderline. 6 In the same country, Gupta et al. 10 reported ovarian tumours were 72.9% benign, 4.1% borderline and 22.9% malignant. In Saudi Arabia, Abdullah 7 found 61.0% of ovarian tumours were benign, 5.2% were borderline and 22% were malignant. In Nepal, Vaidya 8 found 80.72% of ovarian tumour were benign, 3.58% were borderline while 15.70% were malignant. In Pakistan Ahmad et al. 5 found 59.18% ovarian tumour were benign, 3.27% were borderline and 37.54% were malignant. However, in another study in Pakistan, Siddiqui et al. 11 found 79% ovarian tumours were benign and 17.8% were malignant. In India, Mondol et al. 12 found benign tumours were most common (63.1%), followed by malignant (29.6%) and borderline (7.3%).
In Nigeria, 80.3% of the ovarian neoplasms were found benign while malignant ovarian tumours constituted 19.7% of cases. 9 In present study, it was found that 84.95% of ovarian tumours were benign, 1.61% cases were borderline and 13.44% were malignant. Findings of our study were quite similar with study conducted in Nepal. Frequency of malignant ovarian neoplasm of our study was much lower than the some other studies. However, all studies found benign ovarian tumours were more frequent than malignant ones.
Like the studies in India and Pakistan, present study found benign serous tumour was most common type of benign ovarian neoplasm, followed by mature cystic teratoma and benign mucinous tumours ( table 6) .However, some studies conducted in Nepal, Nigeria and North America found mature cystic teratoma was the most common type of benign neoplasm. 8, 9 Serous cystadenocarcinoma was the most common type of malignant neoplasm. It was found as the most common malignant neoplasm in studies conducted in India, Pakistan and Saudi Arabia also. 5, 6, 7, 11 However, in Nepal, mucinous cystadenocarcinoma was found as the most common malignant tumour. 8 Frequency of other common malignant neoplasms also varies slightly in different studies (table 7) .
Similar to present study, other study also showed ovarian tumour had a wide range of age distributions. A study conducted in Indian subcontinent found overall median age for ovarian tumour was 33 years and the median age for benign, borderline and malignant tumour was 32, 47 and 40 years respectively. 4 However, in our study overall median age for ovarian tumour was 50 years and median age of its different types also vary slightly. Similar to the findings of Abdulla et al. 7 , our study also found that the frequency of malignant ovarian neoplasm increases with age, it was most prevalent in more than 50 years of age and all the malignant neoplasm that occurred below 20 years of age was germ cell in origin. Like other studies, 5, 6, 7, 8, 11, 13 our study also found benign tumors were more common than malignant tumours in all age groups.
Present study showed cystic ovarian neoplasm was commonest followed by solid and cystic than predominantly solid. Vaidya et al. 8 found 45.09% ovarian tumors were cystic, 41.17% were solid and cystic and 13.74% were predominantly solid. Frequency of solid and cystic neoplasm was more than present study.
Bilaterality was found in 8.86% cases and 11.29% cases in studies conducted by Vaidya et al. 8 and Sharma et al. 6 respectively. Similar to these, present study also found 11.23 % tumours were bilateral. However, incidence of bilaterality was found much less in studies by Tejeswini et al. 4 and Misra et al. 13 . They found 5.40% and 4.52% of ovarian neoplasms were bilateral respectively.
Conclusion:
In this study it was found that benign ovarian neoplasms were more common than malignant ones. The most common type of benign ovarian neoplasm was benign serous tumour and the most common type of malignant neoplasm was serous cystdenocarcinoma. The pattern and age distribution of ovarian tumours of our study were quite similar with other studies with some variation. This study may be useful in future for further study of ovarian neoplasm in Bangladesh.
